154 related articles for article (PubMed ID: 27737508)
1. The effect of arterial hypertension on thrombosis in low-risk polycythemia vera.
Barbui T; Vannucchi AM; Carobbio A; Rumi E; Finazzi G; Gisslinger H; Ruggeri M; Randi ML; Cazzola M; Rambaldi A; Gisslinger B; Pieri L; Thiele J; Pardanani A; Tefferi A
Am J Hematol; 2017 Jan; 92(1):E5-E6. PubMed ID: 27737508
[No Abstract] [Full Text] [Related]
2. No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials.
Barbui T; Carobbio A; Ghirardi A; Masciulli A; Rambaldi A; Vannucchi AM
Haematologica; 2017 Jun; 102(6):e219-e221. PubMed ID: 28255021
[No Abstract] [Full Text] [Related]
3. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
4. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
[TBL] [Abstract][Full Text] [Related]
5. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis.
Gumina RJ; Foley DA; Tefferi A; Rooke TW; Shields RC
Angiology; 2002; 53(5):587-91. PubMed ID: 12365868
[TBL] [Abstract][Full Text] [Related]
6. In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology.
Barbui T; Carobbio A; Rumi E; Finazzi G; Gisslinger H; Rodeghiero F; Randi ML; Rambaldi A; Gisslinger B; Pieri L; Bertozzi I; Casetti I; Pardanani A; Passamonti F; Vannucchi AM; Tefferi A
Blood; 2014 Nov; 124(19):3021-3. PubMed ID: 25377561
[No Abstract] [Full Text] [Related]
7. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
Landolfi R; Di Gennaro L; Barbui T; De Stefano V; Finazzi G; Marfisi R; Tognoni G; Marchioli R;
Blood; 2007 Mar; 109(6):2446-52. PubMed ID: 17105814
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic complications of polycythemia vera.
Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
[TBL] [Abstract][Full Text] [Related]
9. Segmental portal hypertension and polycythemia vera.
Baniel J; Ziv Y; Wolloch Y
Isr J Med Sci; 1989 Apr; 25(4):202-4. PubMed ID: 2708027
[TBL] [Abstract][Full Text] [Related]
10. [Disorders of the major blood flow due to polycythemia vera].
Gribenko VV; Artemenko OV; Kucher VN; Dudko ET
Vrach Delo; 1988 Oct; (10):28-31. PubMed ID: 3218190
[No Abstract] [Full Text] [Related]
11. Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants.
de Freitas AS; Alvarez-Larrán A
Ann Hematol; 2016 Oct; 95(11):1903-4. PubMed ID: 27518531
[No Abstract] [Full Text] [Related]
12. Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera.
Barbui T; De Stefano V; Ghirardi A; Masciulli A; Finazzi G; Vannucchi AM
Blood Cancer J; 2018 Nov; 8(12):124. PubMed ID: 30478311
[No Abstract] [Full Text] [Related]
13. Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.
Cerquozzi S; Barraco D; Lasho T; Finke C; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Tefferi A
Blood Cancer J; 2017 Dec; 7(12):662. PubMed ID: 29282357
[TBL] [Abstract][Full Text] [Related]
14. Evaluation, treatment and survey of polycythaemia vera.
Godeau P
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):205-8. PubMed ID: 8036143
[No Abstract] [Full Text] [Related]
15. Cardiovascular events and intensity of treatment in polycythemia vera.
Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
[TBL] [Abstract][Full Text] [Related]
16. Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2(V617F) mutational status.
Ohyashiki K; Akahane D; Gotoh A; Ito Y; Tauchi T; Miyazawa K; Kimura Y; Ohyashiki JH
Leukemia; 2007 Dec; 21(12):2544-5. PubMed ID: 17611562
[No Abstract] [Full Text] [Related]
17. ACE inhibitors and cytoreductive therapy in polycythemia vera.
Barbui T; Masciulli A; Ghirardi A; Carobbio A
Blood; 2017 Mar; 129(9):1226-1227. PubMed ID: 28028024
[No Abstract] [Full Text] [Related]
18. Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.
Gisslinger H; Müllner M; Pabinger I; Heis-Vahidi-Fard N; Gisslinger B; Brichta A; Bachleitner-Hofmann T; Mannhalter C
Haematologica; 2005 Mar; 90(3):408-10. PubMed ID: 15749677
[TBL] [Abstract][Full Text] [Related]
19. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
Marchioli R; Finazzi G; Landolfi R; Kutti J; Gisslinger H; Patrono C; Marilus R; Villegas A; Tognoni G; Barbui T
J Clin Oncol; 2005 Apr; 23(10):2224-32. PubMed ID: 15710945
[TBL] [Abstract][Full Text] [Related]
20. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
Bucalossi A; Marotta G; Bigazzi C; Galieni P; Dispensa E
Am J Hematol; 1996 May; 52(1):14-20. PubMed ID: 8638606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
